SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 52.70
+0.40 (0.76%)
Mar 26, 2026, 1:30 PM CST
SCI Pharmtech Revenue
In the year 2025, SCI Pharmtech had annual revenue of 1.34B TWD, down -11.81%. SCI Pharmtech had revenue of 355.47M in the quarter ending December 31, 2025, a decrease of -11.54%.
Revenue
1.34B
Revenue Growth
-11.81%
P/S Ratio
4.69
Revenue / Employee
5.62M
Employees
245
Market Cap
6.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.34B | -180.02M | -11.81% |
| Dec 31, 2024 | 1.52B | 319.58M | 26.54% |
| Dec 31, 2023 | 1.20B | 304.42M | 33.83% |
| Dec 31, 2022 | 899.74M | 35.52M | 4.11% |
| Dec 31, 2021 | 864.22M | -1.83B | -67.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Standard Chemical & Pharmaceutical | 7.02B |
| Formosa Laboratories | 4.85B |
| Orient EuroPharma | 4.60B |
| Handa Pharmaceuticals | 1.62B |
| Maywufa Company | 1.58B |
| Orient Pharma | 1.40B |
| Easywell Biomedicals | 597.41M |
| Foresee Pharmaceuticals | 431.27M |